Emma Walmsley to head up GSK consumer healthcare
March 23, 2010Sales and Marketing GlaxoSmithKline, appointment, consumer healthcare, sales and marketing
GlaxoSmithKline has appointed Emma Walmsley president, Consumer Healthcare Europe and president designate, Worldwide Consumer Healthcare with effect from 1 May. …
PPD boosts position in flu vaccine research
March 23, 2010Research and Development CRO, PPD, Southern Research Institute, vaccines
PPD is collaborating with the Southern Research Institute in the US to tap into the growing market for contract research …
US House passes health reform
March 22, 2010Sales and Marketing Obama, US healthcare
The US House of Representatives has passed an historic bill which represents a major reform for America’s healthcare system. Passed …
CHMP in brief: Hospira’s Nivestim approved
March 22, 2010Research and Development EMA
A round-up of decisions from the Committee for Medicinal Products for Human Use (CHMP), including its recommendation for a chewable version …
Tarceva gets nod for maintenance treatment
March 22, 2010Sales and Marketing Tarceva, lung cancer
Tarceva looks set to gain approval in Europe to treat patients with non-small cell lung cancer whose disease remains stable …
The health crunch: can the NHS flourish in leaner times?
March 22, 2010NHS, NHS funding, qof
The economic downturn which hit the UK in 2009 coincided with a pre-planned slowing down in the investment in the …
Pfizer’s Kindler elected PhRMA chairman
March 22, 2010Research and Development, Sales and Marketing PhRMA, appointment, research and development, sales and marketing
Jeffrey Kindler, chairman and chief executive of Pfizer, has been elected chairman of PhRMA, succeeding AstraZeneca’s chief executive David Brennan …
Merck joins coalition for biosecurity vaccine plant
March 22, 2010Manufacturing and Production, Research and Development biodefence, vaccines
Merck & Co will join in a new US project to create a vaccine research and manufacturing facility designed to …
Baxter Alzheimer’s candidate shows promise
March 20, 2010Research and Development Alzheimer's, baxter
Baxter’s Gammagard has shown promise in treating Alzheimer’s disease, with patients showing better cognitive function and less brain enlargement than …
GSK’s Relovair moves into phase III
March 19, 2010Research and Development GlaxoSmithKline, Relovair, Seretide, Theravance, respiratory
GlaxoSmithKline has started phase III asthma trials of Relovair, the respiratory treatment it is developing with San Francisco biopharma firm …
European approval for ‘double strength’ Faslodex
March 19, 2010Sales and Marketing AstraZeneca, Faslodex, breast cancer
AstraZeneca’s Faslodex has expanded its European licence after winning approval to treat women with hormone receptor-positive breast cancer in a …
Cephalon to develop new class of cancer drug
March 19, 2010Research and Development CRT, Cancer, Cancer Research UK, Cephalon
Pennsylvania-based Cephalon has signed a deal with the discovery arm of charity Cancer Research UK to develop a new class …
LEC appoints Matthew Baker
March 19, 2010Medical Communications Lane Earl Cox, appointment, medical communications
UK healthcare advertising agency Lane Earl Cox (LEC) has appointed Matthew Baker as deputy managing director. He joins LEC from …
Brandcast strengthens healthcare team
March 19, 2010Medical Communications Brandcast, appointment, medical communications
Digital agency Brandcast Media has added two new members to its London-based team. Lily Max (pictured left) joins as video …
Digital Pharma: Novartis’ transplant community
March 19, 2010Medical Communications Novartis, PatientsLikeMe, community, digital pharma, digital pharma research, patient information
Novartis has become the second pharma company to partner with PatientsLikeMe on an online community, working with the site on …
Manufacturing news in brief
March 19, 2010Manufacturing and Production Angel Biotech, Dr Reddy's Laboratories, Fresenius Kabi, Haselmeier, Patheon, W.R. Grace, excipients
Developments in the pharmaceutical manufacturing arena in the last week include facility news for Dr Reddy’s, Dishman, W. R. Grace, …
Talking Point: Responding to trial emergencies
March 19, 2010Research and Development Talking Point, Talking R&D, research and development
Patients taking part in a clinical trial will sometimes experience a medical emergency, at which point the potential need to …
Teva to buy Ratiopharm for €3.6 billion
March 18, 2010Sales and Marketing Ratiopharm, Teva
Teva has secured the acquisition of German generics business Ratiopharm with a last minute bid of 3.62 billion euros. Teva …
IMS adds countries to ‘pharmerging’ hit-list
March 18, 2010Sales and Marketing China, IMS, em
IMS Health has added 10 more countries to its list of ‘pharmerging markets’ which represent the future of pharma industry …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
